Sign in

CIK 0001781174 · <br>Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
825125532
Phone
617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 3 Insider Initial Statement of Ownership
  14. 4 Insider Changes in Ownership
  15. 8-K Event Regulation FD disclosure
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Regulation FD disclosure

Page 7 of 18 · 348 filings